Verona Pharma PLC ADR

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$31.60-$106.93
Market Cap
$9B
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$221.6M
Revenue Growth (YoY)
0%
Gross Profit (12 Mos)
$210.9M
Diluted EPS
-$1.04

News

See more

Yahoo Finance • 24 hours ago

Merck Completes $10B Acquisition of Verona Pharma, Adds COPD Drug Ohtuvayre

Yahoo Finance • 6 days ago

Verona Pharma plc (VRNA)’s Shareholders Authorizes the $10 Billion Acquisition of Verona Pharma plc (VRNA); Nasdaq Trading to Suspend

Yahoo Finance • 7 days ago

VRNA Quantitative Stock Analysis

Yahoo Finance • 8 days ago

Aehr Test Systems Non-GAAP EPS of $0.01, revenue of $11M beats by $0.23M

About

CEO
Dr. David Scott Zaccardelli Pharm.D.
Address
3 More London Riverside, London, United Kingdom, SE1 2RE
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
209